The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider King Rachel K. since year 2005.
The trader's CIK number is 1589712.
At the time of the last reporting, King Rachel K. was the President, CEO of Novavax Inc .
(stock ticker symbol NVAX).
See this page for all insider trading activities at Novavax Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-06-18||GLYC||Glycomimetics Inc||Option Ex||100,000||1.12||112,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by King Rachel K. (President, CEO of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.